SCHEMBL532271

SCHEMBL532271

c1cncc(-c2cccc(-c3cc(-c4cccc(-c5cccnc5)c4)cc(-c4cc(-c5cccc(-c6cccnc6)c5)cc(-c5cccc(-c6cccnc6)c5)c4)c3)c2)c1

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2A6 P11509 6/20 0.75
ALDH1A1 P00352 2/20 0.75
CYP3A4 P08684 2/20 0.75
CYP1A2 P05177 1/20 0.75
MEN1 O00255 1/20 0.69
PSIP1 O75475 1/20 0.69
AXL P30530 1/20 0.69
MKNK1 Q9BUB5 1/20 0.69
MKNK2 Q9HBH9 1/20 0.69
CYP11B1 P15538 5/20 0.61
CYP11B2 P19099 5/20 0.61
CYP19A1 P11511 3/20 0.61
CYP17A1 P05093 1/20 0.61
KMO O15229 1/20 0.60
EPHX2 P34913 1/20 0.56
PRMT6 Q96LA8 1/20 0.56
KDM4E B2RXH2 1/20 0.56
LMNA P02545 1/20 0.56
TP53 P04637 1/20 0.56
MAPT P10636 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12129614 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL12129596 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL12129595 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL22428556 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL12108690 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL669546 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL472057 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL22428551 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL20930856 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1
SCHEMBL29362911 1.00 CYP2A6 (0.75) CYP2A6ALDH1A1CYP3A4CYP1A2MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 124 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114940684-A White light luminescent copper halide complex and preparation method and application thereof 浙江大学温州研究院 2022-08-26 CN claimed
US-20240215280-A1 IN SITU CORE/SHELL PEROVSKITE NANOCRYSTAL MATERIAL, METHOD OF PREPARATION THEREOF, AND LIGHT EMITTING DEVICE COMPRISING THE SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2024-06-27 US disclosed
US-20240215280-A1 IN SITU CORE/SHELL PEROVSKITE NANOCRYSTAL MATERIAL, METHOD OF PREPARATION THEREOF, AND LIGHT EMITTING DEVICE COMPRISING THE SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2024-06-27 US disclosed
CN-114940684-B White light-emitting copper halide complex and preparation method and application thereof 浙江大学温州研究院 2023-07-21 CN disclosed
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-05-11 US disclosed
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-05-11 US disclosed
US-RE49343-E1 Organic electroluminescence device IDEMITSU KOSAN CO., LTD. (JP) 2022-12-20 US disclosed
CN-114940684-A White light luminescent copper halide complex and preparation method and application thereof 浙江大学温州研究院 2022-08-26 CN disclosed
CN-114787170-A Pyrromethene boron complex, and light-emitting element, display device, and lighting device each containing same 东丽株式会社 2022-07-22 CN disclosed
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION (KR) 2022-06-23 US disclosed
US-20120248968-A1 ORGANIC ELECTROLUMINESCENCE DEVICE IDEMITSU KOSAN CO., LTD. 2012-10-04 US disclosed
US-20120242255-A1 NEW IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2012-09-27 US disclosed
US-20120242255-A1 NEW IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2012-09-27 US disclosed
US-20120032115-A1 LIGHT EMITTING DEVICE AND DISPLAY UNIT RICOH COMPANY, LTD. (JP) 2012-02-09 US disclosed
EP-2416392-A2 Light emitting device and display unit Ricoh Company, Ltd. (JP) 2012-02-08 EP disclosed
EP-2413393-A2 Method for manufacturing organic light emitting device and solution for organic light emitting device Kabushiki Kaisha Toshiba (JP) 2012-02-01 EP disclosed
WO-2011070990-A1 NEW IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME CANON KABUSHIKI KAISHA (JP) 2011-06-16 WO disclosed
EP-2275409-A1 Bipiridine derivative and organic electroluminescence element containing the same Yamagata Promotional Organization for Industrial Technology (JP) 2011-01-19 EP disclosed
US-20100327265-A1 BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) 2010-12-30 US disclosed
US-20100327265-A1 BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME YAMAGATA PROMOTIONAL ORGANIZATION FOR INDUSTRIAL TECHNOLOGY (JP) 2010-12-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220194969-A1 METAL HALIDE PEROVSKITE LIGHT EMITTING DEVICE AND METHOD FOR MANUFACTURING SAME HCN4, SLC46A1, FES CYP2A6 1762/4885ALDH1A1 1736/4885CYP3A4 1562/4885
US-20120242255-A1 NEW IRIDIUM COMPLEX AND ORGANIC LIGHT-EMITTING DEVICE CONTAINING SAME INO80C, PCID2, ORC3 CYP2A6 2623/4885ALDH1A1 660/4885CYP3A4 209/4885
US-20230146030-A1 ARYLAMINE COMPOUND, ELECTRONIC COMPONENT USING SAME AND ELECTRONIC DEVICE OCIAD2, AOC2, OCIAD1 CYP2A6 243/4885ALDH1A1 442/4885CYP3A4 83/4885
US-20100327265-A1 BIPIRIDINE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE ELEMENT CONTAINING THE SAME NFE2L2, SLC19A2, AOC2 CYP2A6 613/4885ALDH1A1 260/4885CYP3A4 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.